NCT03310242

Brief Summary

This study aimed to compare the effects between sunlight exposure and oral vitamin D supplementation on serum 25-hydroxyvitamin D concentration and metabolic markers in Korean young adults.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2015

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 16, 2017

Completed
Last Updated

October 31, 2017

Status Verified

June 1, 2016

Enrollment Period

6 months

First QC Date

July 31, 2017

Last Update Submit

October 29, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Serum 25(OH)D

    Changes in serum 25(OH)D levels in ng/mL

    Baseline, 4 week, and 8 week

Secondary Outcomes (13)

  • BMI

    Baseline, 4 week, and 8 week

  • Systolic blood pressure

    Baseline, 4 week, and 8 week

  • Diastolic blood pressure

    Baseline, 4 week, and 8 week

  • Lipid panel

    Baseline and 8 week

  • Fasting glucose

    Baseline and 8 week

  • +8 more secondary outcomes

Study Arms (3)

Sunlight Exposure

EXPERIMENTAL

Everyday sunlight exposure around noon for 20-30 minutes for 8 weeks

Behavioral: Sunlight Exposure

Vitamin D Supplementation

EXPERIMENTAL

Supplementation of vitamin D3 500 IU/day for 8 weeks

Dietary Supplement: Vitamin D Supplementation

Placebo

PLACEBO COMPARATOR

Intake of placebo for 8 weeks

Other: Placebo

Interventions

* Everyday sunlight exposure around noon for 20-30 minutes for 8 weeks * Completing a Sun Diary after sunlight exposure

Sunlight Exposure
Vitamin D SupplementationDIETARY_SUPPLEMENT

\- Supplementation of vitamin D3 500 IU/day for 8 weeks

Vitamin D Supplementation
PlaceboOTHER

\- Intake of placebo for 8 weeks

Placebo

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Serum 25(OH)vitamin D \< 12ng/mL
  • age between 18 and 39 years
  • Korean men and women

You may not qualify if:

  • Vitamin D supplementation within 2 months
  • Photosensitivity or UV allergy
  • History of hyperparathyroidism/hypercalciuria/kidney stone/skin cancer and other cancer
  • Under medication for hypertension, dyslipidemia, and diabetes
  • Intake of photosensitive medicine during study period
  • Exposure of strong UV (e.g., beach, sun tanning) during study period
  • Pregnant/breast-feeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Joh HK, Hwang SS, Cho B, Lim CS, Jung SE. Effect of sun exposure versus oral vitamin D supplementation on serum 25-hydroxyvitamin D concentrations in young adults: A randomized clinical trial. Clin Nutr. 2020 Mar;39(3):727-736. doi: 10.1016/j.clnu.2019.03.021. Epub 2019 Mar 21.

MeSH Terms

Conditions

Vitamin D Deficiency

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Hee-Kyung Joh, PhD

    Seoul National University College of Medicine/Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2017

First Posted

October 16, 2017

Study Start

June 1, 2015

Primary Completion

November 25, 2015

Study Completion

November 30, 2015

Last Updated

October 31, 2017

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share